Status:
UNKNOWN
FLuorescence Cholangiography Using Methylene Blue
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Oxford University Hospitals NHS Trust
Conditions:
Bile Duct Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Open label prospective, non-randomised proof of principle study assessing the use of methylene blue fluorescence cholangiography.
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Undergoing laparoscopic cholecystectomy
Exclusion
- Patient who is unable or unwilling to give informed consent
- Known allergy to methylene blue
- Risk of serotonin syndrome (taking SSRI / G6PD deficiency / previous serotonin syndrome)
- Significant renal failure
- Pregnant / planning pregnancy or breastfeeding
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03386201
Start Date
January 1 2018
End Date
June 1 2018
Last Update
December 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom, OX3 9DS